| Overview upon miR-21 in lung cancer: focus on NSCLC C Bica-Pop, R Cojocneanu-Petric, L Magdo, L Raduly, D Gulei, ... Cellular and Molecular Life Sciences 75, 3539-3551, 2018 | 217 | 2018 |
| The silent healer: miR-205-5p up-regulation inhibits epithelial to mesenchymal transition in colon cancer cells by indirectly up-regulating E-cadherin expression D Gulei, L Magdo, A Jurj, L Raduly, R Cojocneanu-Petric, A Moldovan, ... Cell death & disease 9 (2), 66, 2018 | 88 | 2018 |
| Understanding the role of non-coding RNAs in bladder cancer: from dark matter to valuable therapeutic targets C Pop-Bica, D Gulei, R Cojocneanu-Petric, C Braicu, B Petrut, ... International journal of molecular sciences 18 (7), 1514, 2017 | 58 | 2017 |
| MiR-181 family-specific behavior in different cancers: a meta-analysis view C Pop-Bica, S Pintea, R Cojocneanu-Petric, G Del Sal, S Piazza, ZH Wu, ... Cancer and Metastasis Reviews 37, 17-32, 2018 | 57 | 2018 |
| The clinical utility of miR-21 and let-7 in non-small cell lung cancer (NSCLC). A systematic review and meta-analysis C Pop-Bica, S Pintea, L Magdo, R Cojocneanu, D Gulei, M Ferracin, ... Frontiers in oncology 10, 516850, 2020 | 33 | 2020 |
| Prognostic value of MiR-21: an updated meta-analysis in Head and Neck Squamous Cell Carcinoma (HNSCC) AI Irimie-Aghiorghiesei, C Pop-Bica, S Pintea, C Braicu, R Cojocneanu, ... Journal of clinical medicine 8 (12), 2041, 2019 | 28 | 2019 |
| New insights in gene expression alteration as effect of paclitaxel drug resistance in triple negative breast cancer cells A Jurj, LA Pop, O Zanoaga, CA Ciocan-Cârtiţă, R Cojocneanu, ... Cell. Physiol. Biochem 54 (4), 648-664, 2020 | 25 | 2020 |
| New insights in gene expression alteration as effect of doxorubicin drug resistance in triple negative breast cancer cells CA Ciocan-Cartita, A Jurj, O Zanoaga, R Cojocneanu, LA Pop, ... Journal of Experimental & Clinical Cancer Research 39, 1-16, 2020 | 24 | 2020 |
| Cellular and molecular profiling of tumor microenvironment and early-stage lung cancer R Pirlog, P Chiroi, I Rusu, AM Jurj, L Budisan, C Pop-Bica, C Braicu, ... International journal of molecular sciences 23 (10), 5346, 2022 | 21 | 2022 |
| Tiny actors in the big cellular world: Extracellular vesicles playing critical roles in cancer A Jurj, C Pop-Bica, O Slaby, CD Ştefan, WC Cho, SS Korban, ... International journal of molecular sciences 21 (20), 7688, 2020 | 14 | 2020 |
| Next-generation sequencing in lung cancer patients: a comparative approach in NSCLC and SCLC mutational landscapes C Pop-Bica, CA Ciocan, C Braicu, A Haranguș, M Simon, A Nutu, LA Pop, ... Journal of Personalized Medicine 12 (3), 453, 2022 | 12 | 2022 |
| Emerging roles and mechanisms of semaphorins activity in cancer C Bica, A Tirpe, A Nutu, C Ciocan, S Chira, ES Gurzau, C Braicu, ... Life Sciences 318, 121499, 2023 | 10 | 2023 |
| Genome editing approaches with CRISPR/Cas9 for cancer treatment: Critical appraisal of preclinical and clinical utility, challenges, and future research S Chira, A Nutu, E Isacescu, C Bica, L Pop, C Ciocan, I Berindan-Neagoe Cells 11 (18), 2781, 2022 | 9 | 2022 |
| Identification of potential microRNA panels for male non-small cell lung cancer identification using microarray datasets and bioinformatics methods A Haranguș, R Lajos, L Budisan, O Zanoaga, C Ciocan, C Bica, R Pirlog, ... Journal of personalized medicine 12 (12), 2056, 2022 | 6 | 2022 |
| Identification of a miRNA panel with a potential determinant role in patients suffering from periodontitis O Baru, L Raduly, C Bica, P Chiroi, L Budisan, N Mehterov, C Ciocan, ... Current issues in molecular biology 45 (3), 2248-2265, 2023 | 2 | 2023 |
| The CRISPR/Cas9 Genome-editing System: Principles and Applications C Pop-Bica, A Nutu, R Cojocneanu, S Chira, I Berindan-Neagoe CRISPR-/Cas9 Based Genome Editing for Treating Genetic Disorders and …, 2022 | 2 | 2022 |
| Profiling canine mammary tumors: A potential model for studying human breast cancer LM Gherman, P Chiroi, A Nuţu, C Bica, I Berindan-Neagoe The Veterinary Journal, 106055, 2023 | 1 | 2023 |
| Turning tables for CRISPR/Cas9 editing system: From scratch to advanced delivery platforms S Chira, A Nutu, C Bica, L Pop, M Gherman, M Angheluta, ... Handbook of Cancer and Immunology, 1-27, 2022 | 1 | 2022 |
| miRNA patterns in male LUSC patients-the 3-way mirror: Tissue, plasma and exosomes C Bica, A Jurj, A Harangus, C Ciocan, A Moldovan, O Zanoaga, C Burz, ... Translational Oncology 44, 101951, 2024 | | 2024 |
| The Evaluation of a 5-miRNA Panel in Patients with Periodontitis Disease O Baru, L Pop, L Raduly, C Bica, N Mehterov, R Pirlog, S Buduru, ... JDR Clinical & Translational Research, 23800844241252395, 2024 | | 2024 |
